THE RETAIL BULLETIN - The home of retail news
Click here
Home Page
News Categories
Commentary
Department Stores
Electricals and Tech
Entertainment
Fashion
Food and Drink
General Merchandise
Grocery
Health and Beauty
Home and DIY
Interviews
People Matter
Retail Business Strategy
Property
Retail Solutions
Electricals & Technology
Sports and Leisure
Christmas Ads
Shopping Centres, High Streets & Retail Parks
Retail Events
People in Retail Awards 2024
Omnichannel Futures 2024
Retail HR Central 2024
The Future of The High Street 2024
Retail HR Summit
THE Retail Conference
Upcoming Retail Events
Past Retail Events
Retail Insights
Retail Solutions
Advertise
About
Contact
Subscribe for free
Terms and Policies
Privacy Policy
Dr. Martens stumbles on profit

While Dr Martens has seen its annual revenue rise by 10% to reach £1 billion for the first time, the footwear retailer has posted a 26%… View Article

FASHION RETAIL NEWS UK

Dr. Martens stumbles on profit

While Dr Martens has seen its annual revenue rise by 10% to reach £1 billion for the first time, the footwear retailer has posted a 26% drop in pre-tax profit.

In the year to 31 March, EBITDA fell by 7% to £245 million due to slower revenue growth, investment in new stores, marketing and people, and £15 million costs relating to issues at its Los Angeles distribution centre.

Meanwhile, pre-tax profit fell to £159.4 million from £214.3 million in the prior year.

While direct-to-consumer sales rose by 16% in the period, retail and ecommerce sales increased by 30% and 6% respectively.

Kenny Wilson, Dr Martens chief executive, said: “We achieved annual revenue of £1 billion for the first time, up 10% and up 4% in constant currency.

“Reaching this milestone is testament to the strength of our brand, our long-standing DOCS strategy and the hard work and dedication of our fantastic people globally. Direct to consumer is now more than half our revenue and the Dr. Martens brand remains strong with all key metrics either ahead of, or in line with, last year.

“In EMEA and Japan, where we executed our strategy well, performance was very good with encouraging momentum going into the new financial year.”

Dr. Martens said trading since the start of the new financial year has been in line with  expectations with “very good” direct-to-consumer growth. Therefore, the brand is maintaining its revenue guidance for the year of mid to high single digit growth in constant currency.

Wilson added: “We are focused on the successful execution of our proven DOCS strategy, which we will underpin with continued investment in the business and our people to support our increasing scale and capitalise on our iconic brand’s strength. The board retains its conviction in the strategy, long-term growth and cash generation of the business.”

Subscribe For Retail News